Forigerimod TFA (IPP-201101 TFA) is aCD4T-cellmodulator. Forigerimod TFA is a 21-amino-acid fragment of U1 small nuclear ribonucleoprotein 70 kDa that is phosphorylated at Ser140. Forigerimod TFA can potently inhibitautophagy. Forigerimod can be used for the research of autoimmune disorders, such as systemic lupus erythematosus (SLE)^[1][2][3][4].

Forigerimod TFA (P140) (i.v.; 100 μg in 100 μL saline per mouse) 直接作用于分子伴侣介导的自噬，使 MRL/lpr 小鼠免于唾液腺中发生的细胞浸润和自噬缺陷^[4]。

2752.96

Solid

C₁₁₉H₁₈₂F₃N₃₄O₃₄PS

RIHMVYSKR-{Ser-phosphono}-GKPRGYAFIEY (TFA)

Room temperature in continental US; may vary elsewhere.

Sealed storage, away from moisture and light, under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)

H₂O : 100 mg/mL(36.32 mM;Need ultrasonic)

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture and light, under nitrogen)。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。